About Us

Milltrust International Group is co-headquartered in the asset management hubs of London and Singapore, with a local presence, affiliates, and strategic partnerships spanning across the globe.

Asset Management

Milltrust delivers sustainable investment solutions in public and private markets, focusing on ‘One Health’ and addressing emerging economies, food demand, technology, and climate change, aligning wealth with sustainable prosperity.

Wealth Management

East West Private Wealth stands as a premier global Multi-Family office, offering unparalleled, tailored wealth management services and sustainable, eco-conscious investment solutions, crafting legacies across the globe with transparency, flexibility, and integrity.

News & Media

News

All the latest news, articles, commentaries, press releases, and media coverage of Milltrust International Group and its affiliates.

Contact Us

Milltrust International Group is co-headquartered in the asset management hubs of London and Singapore, with regional presence and strategic partnerships around the world.

Home

\
News
\
News & Media
\
Why Gates and Zuck think the next drug blockbusters will come from your gut

Why Gates and Zuck think the next drug blockbusters will come from your gut

April 9, 2020

BY Alexander Kalis
GROUP MANAGING DIRECTOR

On the bravest frontier in human health, scientists are using bacteria from the digestive system to create novel medicines for a huge range of ailments including Parkinson’s, cancer and autism. The results could transform lives and deliver massive returns for early investors

Milltrust’s VC partner Cerracap was a day 1 investor into Viome. We are proud to have helped pioneered this fascinating technology which uses AI to analyse millions of data points derived from the contents of our gut.